HtrA1, a Potential Predictor of Response to Cisplatin-Based Combination Chemotherapy in Gastric Cancer
Histopathology - United Kingdom
doi 10.1111/j.1365-2559.2011.03818.x
Full Text
Open PDFAbstract
Available in full text
Date
March 30, 2011
Authors
Publisher
Wiley